Company Monitoring Page for AbbVie

latest headlines for company on cafepharma

AbbVie Taps Harvard University for Viral Infection Research Partnership
BioSpace
Wed, 08/26/20 - 10:53 am
Tags:
AbbVie, Harvard, R&D, viral infections, coronaviruses, hemorrhagic fever
AbbVie's Skyrizi stands to gain as docs move away from older psoriasis meds—Amgen's Otezla included
Fierce Pharma
Tue, 08/25/20 - 11:12 am
Tags:
psoriasis, AbbVie, Skyrizi, Amgen, Celgene, Otezla
AbbVie options integrin-based compounds from Morphic, paving way for potential fibrosis treatments
Endpoints
Tue, 08/25/20 - 10:31 am
Tags:
Morphic Therapeutics, AbbVie, idiopathic pulmonary fibrosis
AbbVie keeps TV ad lead in July, Roche and Pfizer follow in mildly curbed pharma TV market
Fierce Pharma
Mon, 08/24/20 - 10:18 am
Tags:
television ads, Roche, Pfizer, AbbVie, pandemic, DTC ads, COVID-19
The duvelisib hot potato is tossed to a new owner as Verastem looks to reorganize around the pipeline
Endpoints
Mon, 08/10/20 - 10:59 pm
Tags:
duvelisib, Verastem, AbbVie
AbbVie OKs $24M lawsuit settlement, accused of using nurses to boost Humira
Beckers Hospital Review
Sat, 08/8/20 - 10:48 pm
Tags:
AbbVie, Humira, kickbacks, nurses, physicians
AbbVie cuts Editas CRISPR pact it inherited from Allergan
Fierce Biotech
Fri, 08/7/20 - 10:52 am
Tags:
Editas Medicine, Allergan, AbbVie, gene editing, CRISPR
AbbVie cans Voyager Alzheimer’s, Parkinson’s gene therapy pacts
Fierce Biotech
Tue, 08/4/20 - 11:07 am
Tags:
AbbVie, Alzheimer's disease, Parkinson's Disease, Voyager Therapeutics
Platform study designed to rapidly screen potential Covid-19 drugs enrolls first patients
MedCity News
Mon, 08/3/20 - 11:28 pm
Tags:
COVID-19, Amgen, AbbVie, Takeda, patients, clinical trials
AbbVie shares rises on strong Q2, though cosmetic Botox sales tumbled 43%
Marketwatch
Fri, 07/31/20 - 11:17 pm
Tags:
AbbVie, earnings
AbbVie preps a challenge to a rival migraine drug from Biohaven, spelling out an upbeat set of PhIII data
Endpoints
Thu, 07/30/20 - 10:56 am
Tags:
AbbVie, migraine, Nurtec, atogepant, Biohaven
How Abbvie Closed The Strategic Distance Of Its Remote Teams
Forbes
Mon, 07/27/20 - 11:12 am
Tags:
AbbVie, COVID-19, pandemic, strategy
AbbVie, already famous for its Humira strategy, forms another 'patent wall' around Imbruvica: report
Fierce Pharma
Wed, 07/22/20 - 11:47 pm
Tags:
AbbVie, Humira, patents, Imbruvica, cancer
AbbVie's Rinvoq Hits the Mark in Pivotal Phase III Dermatitis Trial
BioSpace
Wed, 07/22/20 - 11:37 pm
Tags:
AbbVie, Rinvoq, atopic dermatitis, clinical trials
AbbVie's 'drip-feed' of patents shields top cancer drug from competition, group says
BioPharma Dive
Wed, 07/15/20 - 11:12 pm
Tags:
AbbVie, Imbruvcia, patents, cancer
AbbVie draws first blood in trade secrets war between Allergan's Botox and Evolus
Fierce Pharma
Wed, 07/8/20 - 11:52 pm
Tags:
AbbVie, Allergan, Evolus, Botox, Jeuveau, Daewoong Pharmaceuticals
Pfizer, Novartis and more halt July ads on Facebook to protest hate and racism
Fierce Pharma
Thu, 07/2/20 - 11:33 pm
Tags:
racism, pharma advertising, Pfizer, Novartis, AbbVie
Large UK study finds no benefit to HIV antiviral in COVID-19
BioPharma Dive
Tue, 06/30/20 - 11:31 pm
Tags:
HIV, antivirals, COVID-19, pandemic, Kaletra, AbbVie
FDA rejects AbbVie's eye drug, citing safety concerns
BioPharma Dive
Fri, 06/26/20 - 01:00 pm
Tags:
Allergan, AbbVie, FDA, abicipar, Molecular Partners, wet age-related macular degeneration
Docs 'excited' to learn more about new migraine drugs from Biohaven, Lilly and AbbVie: analyst
Fierce Pharma
Thu, 06/25/20 - 10:53 am
Tags:
migraines, physicians, Biohaven, Eli Lilly, AbbVie, Nurtec ODT, Ubrelvy, Reyvow

Pages

last 30 twitter posts

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.